Chemoprevention in Patients with Peutz‐Jeghers Syndrome: Lessons Learned

Conclusion.Due to accrual problems, no conclusions can be drawn about the value of everolimus in PJS treatment, questioning the feasibility of this agent for chemoprevention.

Source: The Oncologist - April 12, 2018 Category: Cancer & Oncology Authors: Justin de Brabander, Ferry A.L.M. Eskens, Susanne E. Korsse, Evelien Dekker, Pieter Dewint, Monique E. van Leerdam, Susanne van Eeden, Heinz-Josef Klumpen Tags: Chinese Edition, Clinical Trial Results, Gastrointestinal Cancer Source Type: research